Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumococcal polysaccharide vaccines.

R Austrian1

  • 1Department of Research Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

Reviews of Infectious Diseases
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Toxemia and of Neural Injury in the Outcome of Pneumococcal Meningitis.

Transactions of the American Clinical and Climatological Association·2011
Same author

STUDIES ON THE ANTIBACTERIAL ACTION OF THE SULFONAMIDE DRUGS : II. THE POSSIBLE RELATION OF DRUG ACTIVITY TO SUBSTANCES OTHER THANp-AMINOBENZOIC ACID.

The Journal of experimental medicine·2009
Same author

Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.

Vaccine·2001
Same author

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

The Pediatric infectious disease journal·2000
Same author

Pneumococcal vaccines for the world.

Drugs & aging·2000
Same author

A brief history of pneumococcal vaccines.

Drugs & aging·2000
Same journal

Fatal necrotizing otitis externa in a patient with AIDS.

Reviews of infectious diseases·1991
Same journal

Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.

Reviews of infectious diseases·1991
Same journal

A new case of meningitis due to Pasteurella multocida.

Reviews of infectious diseases·1991
Same journal

Disseminated pelvic actinomycosis presenting as metastatic carcinoma: association with the progestasert intrauterine device.

Reviews of infectious diseases·1991
Same journal

Genetically engineered attenuated herpes simplex viruses.

Reviews of infectious diseases·1991
Same journal

Role of altered drug metabolism in virus-drug interactions.

Reviews of infectious diseases·1991
See all related articles

Pneumococcal infections cause significant childhood illness and death. Vaccines using polysaccharide-protein conjugates in infancy, followed by polysaccharide vaccines later, show promise in preventing these infections.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Pneumococcal infections are a leading cause of childhood morbidity and mortality globally.
  • Increasing antibiotic resistance in pneumococci necessitates effective prophylactic strategies.
  • Immune system maturation in children affects vaccine responsiveness to bacterial polysaccharides.

Purpose of the Study:

  • To evaluate the efficacy of novel pneumococcal vaccines in early childhood.
  • To explore strategies for enhancing immunogenicity and immune memory against pneumococcal serotypes.
  • To reduce the future incidence of pneumococcal infections through immunization.

Main Methods:

  • Investigating the immunogenicity of polysaccharide-protein conjugate vaccines in infants.

Related Experiment Videos

  • Assessing the development of IgM and IgG antibodies and immunologic memory.
  • Studying the responsiveness to purified polysaccharide vaccines after age 10.

    • Main Results:

    • Polysaccharide-protein conjugate vaccines are immunogenic in infancy.
    • These conjugate vaccines stimulate robust IgM and IgG antibody production and immunologic memory.
    • A combined vaccination strategy shows potential for significant infection reduction.

    Conclusions:

    • Vaccination with polysaccharide-protein conjugates in infancy is effective.
    • Subsequent administration of purified polysaccharide vaccines after age 10 enhances protection.
    • This immunization schedule offers a promising approach to reduce pneumococcal disease burden in children.